New hope for spinal cord injury: first human test of cell delivery device
NCT ID NCT06841770
Summary
This early-stage study is testing the safety of a new device designed to deliver a cell therapy called LCTOPC1 directly to the spinal cord. It will enroll 10 people with recent (21-42 days) or older (1-5 years) spinal cord injuries in the neck or upper back. The main goal is to see if the delivery device and procedure are safe, with the long-term hope that the cell therapy could help improve function and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rancho Research Institue
NOT_YET_RECRUITINGDowney, California, 90242, United States
Contact Email: •••••@•••••
Contact
-
University of California, San Diego
RECRUITINGLa Jolla, California, 92037, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.